The Role of Non-HDL Cholesterol in Risk Stratification for Coronary Artery Disease-Reference-Cited by-同舟云学术

The Role of Non-HDL Cholesterol in Risk Stratification for Coronary Artery Disease

Published:2011-12-28 Issue:2 Volume:14 Page:130-134
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Rana Jamal S.,Boekholdt S. Matthijs,Kastelein John J. P.,Shah Prediman K.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11883-011-0224-x.pdf

Reference30 articles.

1. Kannel WB, Dawber TR, Thomas Jr HE, McNamara PM. Comparison of serum lipids in the prediction of coronary heart disease. Framingham Study indicates that cholesterol level and blood pressure are major factors in coronary heart disease; effect of obesity and cigarette smoking also noted. R I Med J. 1965;48:243–50.

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–9.

3. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339:1349–57.

4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7–22.

5. Sacks FM, Pfeffer MA, Moye LA, on behalf of the Cholesterol and Recurrent Events Trial Investigators, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001–9.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of ≥15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1–4;Diabetes Care;2023-10-12

2. New discoveries in the field of metabolism by applying single-cell and spatial omics;Journal of Pharmaceutical Analysis;2023-07

3. Dietary nutrient balances and serum cholesterol: a new approach to an old question;2023-06-20

4. Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study;BMJ Open;2023-01

5. Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia;International Journal of Molecular Sciences;2022-12-21